The Nifty took a breather today at 24,197, but a major policy shift is brewing in the healthcare space.
With the government considering a 10-20% price hike for essential drugs due to West Asia supply shocks, pharma stocks are seeing renewed interest.
Join Sanket Bendre as he analyzes this 3-month temporary window and what it means for the bottom line of top drug makers. Is this your next big sectoral bet?
